title: Nm23-H1 can induce cell cycle arrest and apoptosis in B cells.
abstract: Nm23-H1 is a well-known tumor metastasis suppressor, which functions as a nucleoside-diphosphate kinase converting nucleoside diphosphates to nucleoside triphosphates with an expense of ATP. It regulates a variety of cellular activities, including proliferation, development, migration and differentiation known to be modulated by a series of complex signaling pathway. Few studies have addressed the mechanistic action of Nm23-H1 in the context of these cellular processes. To determine the downstream pathways modulated by Nm23-H1, we expressed Nm23-H1 in a Burkitt lymphoma derived B-cell line BJAB and performed pathway specific microarray analysis. The genes with significant changes in expression patterns were clustered in groups which are responsible for regulating cell cycle, p53 activities and apoptosis. We found a general reduction of cell cycle regulatory proteins including cyclins and cyclin dependent kinase inhibitors (anti proliferation), and upregulation of apoptotic genes which included caspase 3, 9 and Bcl-x. Nm23-H1 was also found to upregulate p53 and downregulate p21 expression. A number of these genes were validated by real time PCR and results from promoter assays indicated that Nm23-H1 expression downregulated cyclin D1 in a dose responsive manner. Further, we show that Nm23-H1 forms a complex with the cellular transcription factor AP1 to modulate cyclin D1 expression levels. BJAB cells expressing Nm23-H1 showed reduced proliferation rate and were susceptible to increased apoptosis which may in part be due to a direct interaction between Nm23-H1 and p53. These results suggest that Nm23-H1 may have a role in the regulation of cell cycle and apoptosis in human B-cells.
authors.affiliation: Division of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India.
authors.forename: Tathagata
authors.initials: T
authors.lastname: Choudhuri
authors.forename: Masanao
authors.initials: M
authors.lastname: Murakami
authors.forename: Rajeev
authors.initials: R
authors.lastname: Kaul
authors.forename: Sushil K
authors.initials: SK
authors.lastname: Sahu
authors.forename: Suchitra
authors.initials: S
authors.lastname: Mohanty
authors.forename: Subhash C
authors.initials: SC
authors.lastname: Verma
authors.forename: Pankaj
authors.initials: P
authors.lastname: Kumar
authors.forename: Erle S
authors.initials: ES
authors.lastname: Robertson
mesh_terms: D017209:Apoptosis / Q000235:genetics*; D001402:B-Lymphocytes; D002051:Burkitt Lymphoma; D002453:Cell Cycle / Q000235:genetics*; D002454:Cell Differentiation / Q000235:genetics; D045744:Cell Line, Tumor; D015536:Down-Regulation; D020869:Gene Expression Profiling; D016158:Genes, p53; D006801:Humans; D054778:NM23 Nucleoside Diphosphate Kinases / Q000235:genetics* / Q000502:physiology; D011401:Promoter Regions, Genetic; D015398:Signal Transduction; D015854:Up-Regulation
chemical_list: D054778:NM23 Nucleoside Diphosphate Kinases; C517938:NME1 protein, human
references.citation: Nucleic Acids Res. 2002 Dec 15;30(24):5465-75
references.pmid: 12490715
references.citation: Taiwan J Obstet Gynecol. 2006 Jun;45(2):107-13
references.pmid: 17197349
references.citation: J Biol Chem. 2002 Jan 11;277(2):1560-7
references.pmid: 11694515
references.citation: Biochem Biophys Res Commun. 2001 Dec 7;289(3):738-43
references.pmid: 11726210
references.citation: J Natl Cancer Inst. 1994 Dec 21;86(24):1838-44
references.pmid: 7990158
references.citation: Virology. 2006 Jul 20;351(1):58-72
references.pmid: 16631833
references.citation: J Natl Cancer Inst. 2005 Jun 1;97(11):836-45
references.pmid: 15928304
references.citation: Cell Death Differ. 2001 May;8(5):470-6
references.pmid: 11423907
references.citation: Int J Cancer. 2004 Mar;109(1):65-70
references.pmid: 14735469
references.citation: Oncogene. 1993 Sep;8(9):2325-33
references.pmid: 8395676
references.citation: Cell. 2003 Mar 7;112(5):659-72
references.pmid: 12628186
references.citation: Cancer Res. 1988 Nov 15;48(22):6550-4
references.pmid: 2460224
references.citation: J Biol Chem. 1996 Oct 11;271(41):25107-16
references.pmid: 8810265
references.citation: J Bioenerg Biomembr. 2000 Jun;32(3):247-58
references.pmid: 11768308
references.citation: Science. 2001 Apr 27;292(5517):727-30
references.pmid: 11326099
references.citation: J Virol. 2006 Apr;80(7):3445-58
references.pmid: 16537612
references.citation: Biochem Biophys Res Commun. 1998 Feb 13;243(2):342-8
references.pmid: 9480811
references.citation: Biochem Biophys Res Commun. 2009 Sep 4;386(4):607-11
references.pmid: 19540190
references.citation: J Virol. 2005 Aug;79(15):9714-24
references.pmid: 16014933
references.citation: J Virol. 2007 Jun;81(12):6718-30
references.pmid: 17409144
references.citation: Biochem Biophys Res Commun. 2004 Aug 6;320(4):1063-8
references.pmid: 15249197
references.citation: J Virol. 2006 Jul;80(13):6411-9
references.pmid: 16775329
references.citation: Cell Growth Differ. 1996 Dec;7(12):1689-95
references.pmid: 8959337
references.citation: Acta Pharmacol Sin. 2008 Dec;29(12):1451-8
references.pmid: 19026164
references.citation: Cancer Res. 2003 Sep 1;63(17):5454-61
references.pmid: 14500381
references.citation: Breast Cancer Res Treat. 1993;25(2):175-87
references.pmid: 8347849
references.citation: Mol Carcinog. 2006 Aug;45(8):627-33
references.pmid: 16739125
references.citation: J Virol. 2006 Feb;80(3):1321-31
references.pmid: 16415009
references.citation: FEBS Lett. 2002 Feb 13;512(1-3):334-40
references.pmid: 11852106
references.citation: Oncogene. 1997 Feb 20;14(7):837-47
references.pmid: 9047391
references.citation: J Biol Chem. 1997 Feb 28;272(9):5525-32
references.pmid: 9038158
references.citation: Mol Carcinog. 2003 Apr;36(4):204-14
references.pmid: 12669312
references.citation: Cancer Res. 2007 Aug 1;67(15):7238-46
references.pmid: 17671192
references.citation: Virology. 2006 Aug 1;351(2):393-403
references.pmid: 16701788
references.citation: Virology. 2009 Jun 5;388(2):236-47
references.pmid: 19394062
references.citation: Int J Cancer. 2008 Aug 1;123(3):500-10
references.pmid: 18470881
references.citation: Am J Pathol. 2005 Sep;167(3):869-77
references.pmid: 16127164
references.citation: Cell Growth Differ. 1992 Dec;3(12):873-9
references.pmid: 1472467
references.citation: Nature. 1989 Nov 9;342(6246):177-80
references.pmid: 2509941
references.citation: Vestn Oftalmol. 2001 Mar-Apr;117(2):27-9
references.pmid: 11510160
references.citation: J Bioenerg Biomembr. 2006 Aug;38(3-4):215-25
references.pmid: 17103045
references.citation: J Biol Chem. 2002 Jun 7;277(23):20895-902
references.pmid: 11919189
references.citation: Virology. 1979 Apr 30;94(2):460-9
references.pmid: 452423
references.citation: Exp Cell Res. 2000 Nov 25;261(1):127-38
references.pmid: 11082283
references.citation: Int J Cancer. 1997 Oct 9;73(2):297-302
references.pmid: 9335458
references.citation: Mol Cell Biol. 2005 Feb;25(4):1379-88
references.pmid: 15684389
references.citation: Cancer Cell. 2004 Feb;5(2):137-49
references.pmid: 14998490
references.citation: J Virol. 2009 May;83(10):4871-83
references.pmid: 19116252
references.citation: J Biol Chem. 2007 Nov 30;282(48):35293-307
references.pmid: 17916563
references.citation: Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716-9
references.pmid: 2823272
references.citation: J Biol Chem. 1998 Jan 2;273(1):1-4
references.pmid: 9417035
references.citation: Comp Biochem Physiol B. 1973 Jun 15;45(2):355-64
references.pmid: 4351428
references.citation: PLoS One. 2009 Nov 23;4(11):e7949
references.pmid: 19956735
references.citation: BMC Mol Biol. 2007 Dec 20;8:113
references.pmid: 18093344
references.citation: Cancer Res. 2007 Dec 15;67(24):11751-9
references.pmid: 18089805
references.citation: Cancer Biol Ther. 2003 Mar-Apr;2(2):196-202
references.pmid: 12750563
references.citation: Cell Cycle. 2008 Sep 15;7(18):2856-67
references.pmid: 18769160
references.citation: J Virol. 2007 Oct;81(19):10352-61
references.pmid: 17634231
references.citation: J Biol Chem. 2005 May 20;280(20):20059-68
references.pmid: 15738001